Synergy High Risk AMD Study
Our research team
CERA has assembled a team of world-class researchers to tackle the ambitious goals of the Synergy High Risk AMD Study.
Together, our research team will conduct the world’s most intensive study to determine what causes a high-risk form of AMD (RPD). Once the pathways are understood, novel approaches to intervening can be developed.
The team comprises clinicians and scientists at CERA, the University of Melbourne and the Walter and Eliza Hall Institute of Medical Research, as well as international research collaborators.
Our collective expertise spans bioinformatics, artificial intelligence, genetics, molecular biology, anatomy, stem cells and clinical ophthalmology.
Professor Robyn Guymer AM
MBBS, PhD, FRANZCO, FAHMS
Professor Guymer leads the research team for the Synergy High Risk AMD Study.
She is a Deputy Director of CERA and the Head of Macular Research at CERA, leading a team of researchers primarily investigating AMD.
She is also Professor of Ophthalmology at Melbourne University and a senior retinal specialist at the Royal Victorian Eye and Ear Hospital.
Dr Zhichao Wu
Dr Wu is a Senior Research Fellow at CERA. He is a clinical researcher, working in the field of innovative diagnostics and outcome measures for eye diseases such as AMD.
His PhD at the University of Melbourne (based at CERA) was awarded the Dean’s Award for Excellence in the PhD Thesis. In 2020 he was awarded the American Academy of Optometry Irvin M and Beatrice Borish Award.
Professor Erica Fletcher
BScOptom, MScOptom, PhD, FAAO
Erica Fletcher is a Professor of Anatomy and Neuroscience at the University of Melbourne and a clinically trained optometrist.
She has over 15 years’ experience in ophthalmological research, particularly understanding retinal diseases.
Professor Alice Pébay
Professor Pébay is a NHMRC Senior Research Fellow and Principal Research Fellow in Anatomy and Neuroscience (University of Melbourne) and Surgery (Royal Melbourne Hospital).
She has 19 years’ experience researching human pluripotent stem cells and is the primary inventor of three international patents related to stem cell technology.
Professor Melanie Bahlo
BSc (Hons), PhD
Professor Bahlo is a statistical geneticist and bioinformatician specialising in neurological and retinal disorders.
She leads a team of bioinformatics researchers at the Walter and Eliza Hall Institute of Medical Research. Her lab uses statistical methodology to describe and model genetic data.
Dr Brendan Ansell
BA, BSc (Hons), PhD
Dr Ansell is a Postdoctoral Fellow in the Population Health and Immunity Division at the Walter and Eliza Hall Institute of Medical Research.
His research focuses on using high-powered computing and statistics to understand the links between genetics, and brain and retinal disorders.